SPONSOR
UNICANCER
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3
Conditions studied: Breast Cancer (Early Breast Cancer)Squamous Cell Carcinoma of Head and NeckBreast CancerProstate Cancer Metastatic
UNICANCER is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Breast Cancer (Early Breast Cancer), Squamous Cell Carcinoma of Head and Neck, Breast Cancer, Prostate Cancer Metastatic.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — UNICANCER
How many clinical trials has UNICANCER sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by UNICANCER, of which 4 are actively recruiting participants. These trials cover conditions including Breast Cancer (Early Breast Cancer), Squamous Cell Carcinoma of Head and Neck, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does UNICANCER research focus on?
UNICANCER clinical trials span Breast Cancer (Early Breast Cancer), Squamous Cell Carcinoma of Head and Neck, Breast Cancer, Prostate Cancer Metastatic. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a UNICANCER clinical trial?
To participate in a UNICANCER trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all UNICANCER trials with current recruitment status updated daily.
Clinical Trials by UNICANCER
NCT07661927 Phase 2
Recruiting
Skipping Hormone Therapy in Low-Risk Early Breast Cancer
Breast Cancer (Early Breast Cancer)
NCT04747054 Phase 3
Recruiting
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
Squamous Cell Carcinoma of Head and Neck
NCT07120087
Recruiting
Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.
Breast Cancer
NCT06496581 Phase 3
Recruiting
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
Prostate Cancer Metastatic
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology